Summary:
The paper discusses the update of GINA 2020 guidelines. The authors discuss the changes and present a critical view of the recommendations. They describe in detail the changes that increase the effectiveness and safety of therapy in patients with asthma.
Keywords: GINA 2020, ICS-LABA combination, SABA overuse, biological therapy, Polish pharmacotherapeutic programs in asthma
If you would like to get the full article in Polish please contact our editorial office via email.
Add new comment